A Pilot Study of Chlorthalidone Among Patients With Poorly Controlled Hypertension and CKD
Status:
Completed
Trial end date:
2013-08-01
Target enrollment:
Participant gender:
Summary
It is estimated that in the United States there are approximately 8 million individuals with
moderate to severe chronic kidney disease (CKD), not on dialysis. Volume expansion plays an
important role in the pathogenesis of hypertension in patients with CKD. For this pilot
study, the investigators hypothesize that administration of chlorthalidone among patients
with moderate to severe CKD will improve blood pressure (BP).